Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes

In Vitro Cellular and Developmental Biology - Animal

Volumn 50, Issue 4, 2014, Pages 275-286

  Vuorenpää, Hanna ^a   Ikonen, Liisa ^a,b   Kujala, Kirsi ^a,b   Huttala, Outi ^a   Sarkanen, Jertta Riina ^a   Ylikomi, Timo ^a,c   Aalto Setälä, Katriina ^a,b,c   Heinonen, Tuula ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angiogenesis; Human adipose stromal cells, in vitro cardiotoxicity; Primary cardiomyocytes

Indexed keywords

RATTUS;

BIOMATERIAL; CULTURE MEDIUM;

ADIPOSE TISSUE; ANIMAL; CELL DIFFERENTIATION; CELL SURVIVAL; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; HEART MUSCLE CELL; HUMAN; PROCEDURES; RAT; STROMA CELL; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL;

ADIPOSE TISSUE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; CULTURE MEDIA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MYOCYTES, CARDIAC; RATS; STROMAL CELLS; TISSUE ENGINEERING;

EID: 84898596867     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-013-9703-4     Document Type: Article

References (46)

1. Banerjee I.; Fuseler J. W.; Price R. L.; Borg T. K.; Baudino T. A. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 293: H1883-91; 2007.
2. Banyasz T.; Lozinskiy I.; Payne C. E.; Edelmann S.; Norton B.; Chen B.; Chen-Izu Y.; Izu L. T.; Balke C. W. Transformation of adult rat cardiac myocytes in primary culture. Exp. Physiol. 93: 370-82; 2008.
3. Bhattacharya S.; MacDonald S. T.; Farthing C. R. Molecular mechanisms controlling the coupled development of myocardium and coronary vasculature. Clin. Sci. (Lond.) 111: 35-46; 2006.
4. Brutsaert D. L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 83: 59-115; 2003.
5. Cao R.; Eriksson A.; Kubo H.; Alitalo K.; Cao Y.; Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestration, and permeability. Circ. Res. 94: 664-70; 2004.
6. Caspi O.; Lesman A.; Basevitch Y.; Gepstein A.; Arbel G.; Habib I. H.; Gepstein L.; Levenberg S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100: 263-72; 2007.
7. De Siena R.; Balducci L.; Blasi A.; Montanaro M. G.; Saldarelli M.; Saponaro V.; Martino C.; Logrieco G.; Soleti A.; Fiobellot S.; Madeddu P.; Rossi G.; Ribatti D.; Crovace A.; Cristini S.; Invernici G.; Parati E. A.; Alessandri G. Omentum-derived stromal cells improve myocardial regeneration in pig post-infarcted heart through a potent paracrine mechanism. Exp. Cell Res. 316: 1804-15; 2010.
8. Ferrara N.; Carver-Moore K.; Chen H.; Dowd M.; Lu L.; O'Shea K. S.; Powell-Braxton L.; Hillan K. J.; Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-42; 1996.
9. Gimble J.; Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5: 362-9; 2003.
10. He W.; Ye L.; Li S.; Liu H.; Wu B.; Wang Q.; Fu X.; Han W.; Chen Z. Construction of vascularized cardiac tissue from genetically modified mouse embryonic stem cells. J. Heart. Lung. Transplant. 31: 204-12; 2012.
11. Hsieh P. C.; Davis M. E.; Lisowski L. K.; Lee R. T. Endothelial-CM interactions in cardiac development and repair. Annu. Rev. Physiol. 68: 51-66; 2006.
12. Hussain A.; Collins G.; Yip D.; Cho C. H. Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds. Biotechnol. Bioeng. 110: 637-47; 2013.
13. Iyer R. K.; Chiu L. L.; Reis L. A.; Radisic M. Engineered cardiac tissues. Curr Opin Biotech 22: 706-14; 2011.
14. Jaffe E. A.; Nachman R. L.; Becker C. G.; Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-56; 1973.
15. Kettenhofen R.; Bohlen H. Preclinical assessment of cardiac toxicity. Drug Discov. Today 13: 702-7; 2005.
16. Kilroy G. E.; Foster S. J.; Wu X.; Ruiz J.; Sherwood S.; Heifetz A.; Ludlow J. W.; Stricker D. M.; Potiny S.; Green P.; Halvorsen Y. D.; Cheatham B.; Storms R. W.; Gimble J. M. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J. Cell. Physiol. 212: 702-9; 2007.
17. Kreutziger K. L.; Muskheli V.; Johnson P.; Braun K.; Wight T. N.; Murry C. E. Developing vasculature and stroma in engineered human myocardium. Tissue Eng. Part. A 17: 1219-28; 2011.
18. Kujala V. J.; Jimenez Z. C.; Väisänen J.; Tanskanen J. M.; Kerkelä E.; Hyttinen J.; Aalto-Setälä K. Averaging in vitro cardiac field potential recordings obtained with microelectrode arrays. Comput. Methods Programs. Biomed. 104: 199-205; 2011.
19. Kyösola K.; Rechardt L.; Merikallio E.; Järvinen A.; Mattila T.; Waris T.; Aalto-Setälä K. Cardioplegia versus topical cooling for cardiac protection during open-heart surgery. An electron microscopic and histochemical study of right atrial biopsies. Ann. Clin. Res. 15: 156-63; 1983.
20. Lasser K. E.; Allen P. D.; Woolhandler S. J.; Himmelstein D. U.; Wolfe S. M.; Bor D. H. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287: 2215-20; 2002.
21. Lesman A.; Gepstein L.; Levenberg S. Vascularization shaping the heart. Ann. N.Y. Acad. Sci 1188: 46-51; 2010.
22. Lexchin J. Drug withdrawals from the Canadian market for safety reasons, 1963-2004. CMAJ 172: 765-7; 2005.
23. Li RK (2002) Cardiomyocytes. In: Koller MR, Palsson BO and Masters JRW, editors. Human Cell Culture: vol V: Primary Mesenchymal Cells. Kluwer. pp. 118-119.
24. Miranville A.; Heeschen C.; Sengenés C.; Curat C. A.; Busse R.; Bouloumíe A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-55; 2004.
25. Montessuit C.; Rosenblatt-Velin N.; Papageorgiou I.; Campos L.; Pellieux C.; Palma T.; Lerch R. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4. Cardiovasc. Res. 64: 94-104; 2004.
26. Nag A. C. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 28: 41-61; 1980.
27. Narang D.; Sood S.; Thomas M. K.; Dinda A. K.; Maulik S. K. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart. BMC Pharmacology 4: 29-38; 2004.
28. Narmoneva D. A.; Vukmirovic R.; Davis M. E.; Kamm R. D.; Lee R. T. Endothelial cells promote cardiac myocyte survival and spatial reorganization. Circulation 110: 962-8; 2004.
29. Norotte C.; Marga F. S.; Niklason L. E.; Forgacs G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30: 5910-7; 2009.
30. Radisic M.; Malda J.; Epping E.; Geng W.; Langer R.; Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93: 332-43; 2006.
31. Radisic M.; Park H.; Martens T. P.; Salazar-Lazaro J. E.; Geng W.; Wang Y.; Langer R.; Freed L. E.; Vunjak-Novakovic G. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J. Biomed. Mater. Res. A 86: 713-24; 2008.
32. Redfern W. S.; Carlsson L.; Davis A. S.; Lynch W. G.; MacKenzie I.; Palethorpe S.; Siegl P. K.; Strang I.; Sullivan A. T.; Wallis R.; Camm A. J.; Hammond T. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovas. Res. 58: 32-45; 2003.
33. Rehman J.; Traktuev D. O.; Li J.; Merfeld-Clauss S.; Temm-Grove C. J.; Bovenkerk J. E.; Pell C. J.; Johnstone B. H.; Considine R. V.; March K. L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-8; 2004.
34. Reppel M.; Pillekamp F.; Lu Z. J.; Halbach M.; Brockmeier K.; Fleischmann B. K.; Hescheler J. Microelectrode arrays: a new tool to measure embryonic heart activity. J. Electrocardiol. 37: 104-9; 2004.
35. Rivron N. C.; Liu J. J.; Rouwkema J.; de Boer J.; van Blitterswijk C. A. Engineering vascularised tissues in vitro. Eur. Cell. Mater. 15: 27-40; 2008.
36. Rubina K.; Kalinina N.; Efimenko A.; Lopatina T.; Melikhova V.; Tsokolaeva Z.; Sysoeva V.; Tkachuk V.; Parfyonova Y. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue. Eng. Part. A 15: 2039-50; 2009.
37. Sadat S.; Gehmert S.; Song Y. H.; Yen Y.; Bai X.; Gaiser S.; Klein H.; Alt E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 363: 674-9; 2007.
38. Sarkanen JR, Mannerström M, Vuorenpää H, Uotila J, Ylikomi T and Heinonen T. (2011) Intralaboratory validation of a human cell based in vitro angiogenesis assay for testing angiogenesis modulators. Front Pharmacol 1. doi: 10.3389/fphar.2010.00147
39. Sarkanen J. R.; Vuorenpää H.; Huttala O.; Mannerström B.; Kuokkanen H.; Miettinen S.; Heinonen T.; Ylikomi T. Adipose stromal cell tubule network model provides a versatile tool for vascular research and tissue engineering. Cells Tissues Organs. 196: 385-97; 2012.
40. Sekine H.; Shimizu T.; Hobo K.; Sekiya S.; Yang J.; Yamato M.; Kurosawa H.; Kobayashi E.; Okano T. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118: S145-52; 2008.
41. Shimizu T.; Yamato M.; Kikuchi A.; Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24: 2309-16; 2003.
42. Stevens K. R.; Kreutziger K. L.; Dupras S. K.; Korte F. S.; Regnier M.; Muskheli V.; Nourse M. B.; Bendixen K.; Reinecke H.; Murry C. E. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. PNAS 106: 16568-73; 2009.
43. Traktuev D. O.; Merfeld-Clauss S.; Li J.; Kolonin M.; Arap W.; Pasqualini R.; Johnstone B. H.; March K. L. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res. 102: 77-85; 2008.
44. Tulloch N. L.; Muskheli V.; Razumova M. V.; Korte F. S.; Regnier M.; Hauch K. D.; Pabon L.; Reinecke H.; Murry C. E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109: 47-59; 2011.
45. Uusimaa P. A.; Hassinen I. E.; Vuolteenaho O.; Ruskoaho H. Endothelin-induced atrial natriuretic peptide release from cultured neonatal cardiac myocytes: the role of extracellular calcium and protein kinase-C. Endocrinology 130: 2455-64; 1992.
46. Valarmathi M. J.; Goodwin R. L.; Fuseler J. W.; Davis J. M.; Yost M. J.; Potts J. D. A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration. Biomaterials 31: 3185-200; 2010.